These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21367665)

  • 41. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review of laquinimod and its therapeutic potential in multiple sclerosis.
    Thöne J; Gold R
    Expert Opin Pharmacother; 2013 Dec; 14(18):2545-52. PubMed ID: 24215556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis.
    Sipe JC
    Expert Rev Neurother; 2010 Mar; 10(3):365-75. PubMed ID: 20187859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Teriflunomide encourages cytostatic and apoptotic effects in premalignant and malignant cutaneous keratinocytes.
    Hail N; Chen P; Rower J; Bushman LR
    Apoptosis; 2010 Oct; 15(10):1234-46. PubMed ID: 20544286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glatiramer in the treatment of multiple sclerosis.
    Rizvi SA; Kim E; Moodie J
    Int J Nanomedicine; 2006; 1(3):283-9. PubMed ID: 17717969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A rapid and simple high-performance liquid chromatography assay for the leflunomide metabolite, teriflunomide (A77 1726), in renal transplant recipients.
    Sobhani K; Garrett DA; Liu DP; Rainey PM
    Am J Clin Pathol; 2010 Mar; 133(3):454-7. PubMed ID: 20154284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus.
    Yao X; Wu Y; Jiang J; Chen X; Liu D; Hu P
    Eur J Pharm Sci; 2019 Aug; 136():104942. PubMed ID: 31154006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
    Neuhaus O; Stüve O; Archelos JJ; Hartung HP
    J Neurol Sci; 2005 Jun; 233(1-2):173-7. PubMed ID: 15949504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnosis and treatment of multiple sclerosis. Update, 2003].
    Jarius S; Hohlfeld R; Voltz R
    MMW Fortschr Med; 2003 May; 145 Suppl 2():88-91, 93, 95. PubMed ID: 14579493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator.
    van Eden W
    Curr Opin Investig Drugs; 2008 May; 9(5):523-33. PubMed ID: 18465663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitoxantrone and cytotoxic drugs' mechanisms of action.
    Vollmer T; Stewart T; Baxter N
    Neurology; 2010 Jan; 74 Suppl 1():S41-6. PubMed ID: 20038762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dimethyl fumarate in relapsing-remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety.
    Dubey D; Kieseier BC; Hartung HP; Hemmer B; Warnke C; Menge T; Miller-Little WA; Stuve O
    Expert Rev Neurother; 2015 Apr; 15(4):339-46. PubMed ID: 25800129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fingolimod: a novel immunosuppressant for multiple sclerosis.
    Brown BA; Kantesaria PP; McDevitt LM
    Ann Pharmacother; 2007 Oct; 41(10):1660-8. PubMed ID: 17785617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of two molecular scaffolds, 5-methylisoxazole-3-carboxamide and 5-methylisoxazole-4-carboxamide.
    Song Y; Zhang Y; Lee AR; Huang WH; Chen B; Palfey B; Shaw J
    Curr Pharm Des; 2014; 20(1):146-52. PubMed ID: 23944378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammatory colitis associated with Teriflunomide.
    Esfahani NZ; von Geldern G; Romba MC; Parikh DA; Wundes A
    Mult Scler Relat Disord; 2020 Nov; 46():102480. PubMed ID: 32942118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.
    Neuhaus O; Hartung HP
    Expert Rev Neurother; 2007 May; 7(5):547-56. PubMed ID: 17492904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral laquinimod therapy in relapsing multiple sclerosis.
    Preiningerova J
    Expert Opin Investig Drugs; 2009 Jul; 18(7):985-9. PubMed ID: 19527103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination therapy in multiple sclerosis.
    Fernández O
    J Neurol Sci; 2007 Aug; 259(1-2):95-103. PubMed ID: 17507031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
    Boĭko OV; Stoliarov ID; Petrov AM; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):78-81. PubMed ID: 24416812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Teriflunomide (Aubagio). New treatment for multiple sclerosis].
    Sabourin G
    Perspect Infirm; 2014; 11(3):56. PubMed ID: 24855766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.